Nephron appoints new chief of staff

Nephron Pharmaceuticals Corp. has named Morgan Nichols Scarnecchia its chief of staff. In her new role, Scarnecchia will implement strategic business initiatives, manage daily operations and work alongside owner and CEO Lou Kennedy in internal and external affairs.  

“As two women who grew up in Lexington, Morgan and I not only share a great passion for the life sciences, but also South Carolina and the Midlands,” Kennedy said in a news release. “She is a great addition to our strong female leadership here at Nephron — and by working together, we will continue to drive Nephron forward.”  

Before joining the Nephron team, Scarnecchia was the director of corporate affairs for KOR Medical, where she built and managed the start-up’s key corporate accounts and communications for its various entities, according to the release.   

Scarnecchia has served as corporate affairs and investor relations manager at SCBIO, where she was responsible for board and investor communications and leading life sciences workforce initiatives like the association’s K-12 education programs. She began her career at the biotechnology organization as its membership and marketing coordinator, recruiting life science companies and implementing new stakeholder engagement strategies.  

In 2019, Scarnecchia was crowned Miss South Carolina. During her reign, she traveled across South Carolina promoting Stronger With STEM, a personal initiative created to promote a 21st-century workforce in the areas of science, technology, engineering and mathematics.  

Scarnecchia has a Bachelor of Science in genetics from Clemson University and is currently pursuing a master’s degree in biotechnology and business from Johns Hopkins University.  

Based in West Columbia, Nephron develops and produces safe, affordable generic inhalation solutions and suspension products. The company also operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals across America in an effort to alleviate drug shortage needs.